BioSig Technologies, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
BSGM Nasdaq 3840 www.biosig.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioSig Technologies, Inc.

BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement - Nov 13th, 2024 8:14 pm
BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel - Oct 22nd, 2024 7:13 pm
BioSig intends to acquire Neuro-Kinesis’ assets - Aug 1st, 2024 8:32 am
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation - Jul 31st, 2024 1:45 pm
BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024 - Jul 25th, 2024 5:57 pm
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer - Jun 10th, 2024 1:45 pm
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - May 30th, 2024 8:05 pm
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - May 30th, 2024 12:00 pm
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders - May 21st, 2024 3:10 pm
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent - May 3rd, 2024 4:22 pm
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately - Apr 30th, 2024 6:03 pm
BioSig Engages Consulting Firm for Business Model Strategies - Apr 4th, 2024 3:35 pm
BioSig Announces Reduction of its Workforce - Feb 20th, 2024 3:00 pm
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases - Feb 6th, 2024 1:30 pm
BioSig Announces Reverse Stock Split - Jan 31st, 2024 4:15 pm
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy - Jan 30th, 2024 1:30 pm